Volumen | 2.323 |
|
|||||
News | - | ||||||
Tageshoch | 3,00 | Niedrig Hoch |
|||||
Tagestief | 2,80 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
3,00 | 2,80 | 3,00 | 2,82 | 3,04 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
47 | 2.323 | US$ 2,89 | US$ 6.704 | - | 1,7501 - 6,75 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
22:02:10 | 33 | US$ 2,98 | USD |
Finanzwerte CYCN
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
7,64M | 2,71M | - | 0 | -5,26M | -1,94 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Cyclerion Therapeutics
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
26.1.2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
11.12.2023 | 23:09 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
04.12.2023 | 23:09 | Edgar (US Regulatory) | Form 8-K - Current report |
04.12.2023 | 14:00 | GlobeNewswire Inc. | Cyclerion Appoints Regina Graul, Ph.D., as President |
01.12.2023 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
01.12.2023 | 00:16 | GlobeNewswire Inc. | Cyclerion Strengthens Board of Directors with Experienced.. |
24.11.2023 | 19:06 | Edgar (US Regulatory) | Form 8-K - Current report |
13.11.2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23.10.2023 | 22:58 | Edgar (US Regulatory) | Form 8-K - Current report |
31.7.2023 | 13:00 | GlobeNewswire Inc. | Tisento Launches with $81 Million From Top-Tier Investor.. |
28.7.2023 | 22:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19.7.2023 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Cyclerion Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
CYCN Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 3,04 | 3,1999 | 2,77 | 2,97 | 886 | -0,22 | -7,24% |
1 Monat | 3,16 | 3,98 | 2,77 | 3,16 | 3.149 | -0,34 | -10,76% |
3 Monate | 2,84 | 4,00 | 2,70 | 3,17 | 2.827 | -0,02 | -0,70% |
6 Monate | 2,50 | 5,25 | 1,7501 | 3,23 | 5.347 | 0,32 | 12,80% |
1 Jahr | 4,536 | 6,75 | 1,7501 | 4,58 | 19.034 | -1,72 | -37,83% |
3 Jahre | 43,60 | 97,20 | 1,7501 | 47,50 | 277.661 | -40,78 | -93,53% |
5 Jahre | 304,20 | 349,20 | 1,7501 | 65,77 | 344.146 | -301,38 | -99,07% |